Atenolol

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Antipressan; Apo-Atenol; AteHexal; Atendol; Beta-Adalat (Bayer); Evitocor; Kalten (BPC); Noten; Novo-Atenol; Nu-Atenol; Taro-Atenol; Tenif (AstraZeneca); Tenolin; Tenoret 50 (AstraZeneca); Tenoretic (AstraZeneca); Tenormin (AstraZeneca); Tenormine
  • INDICATIONS: Angina, hypertension, acute myocardial infarction
  • CLASS: Antiarrhythmic class II, Beta adrenergic blocker, Beta blocker
  • HALF-LIFE: 6–7 hours (adults)
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alfuzosin, Calcium channel blockers, Cisplatin, Clonidine, Digitalis glycosides, Diltiazem, Disopyramide, Epinephrine, Indomethacin, Reserpine, Verapamil

PREGNANCY CATEGORY: D

Contra-indicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, or overt cardiac failure.

Beta-Adalat and Tenif are atenolol and nifedipine. Kalten, Tenoret 50 and Tenoretic are atenolol and chlorthalidone. Chlorthalidone is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.

CESSATION OF THERAPY

See full prescribing information for complete boxed warning.

Our database has 61 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
NEUROMUSCULAR/SKELETAL
OCULAR
RENAL
RESPIRATORY
OTHER


Page last updated 12/07/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top